OBJECTIVE: This study aimed to evaluate the results of the Danish experience with the ProACT urinary continence device inserted in @entity1 with stress @entity322 . MATERIAL AND METHODS: The ProACT was inserted in 114 @entity1 . Data were registered prospectively. The main endpoints were complications, pad use per day and 24 h urinary leakage. A questionnaire evaluating symptoms and satisfaction was sent to the @entity1 . RESULTS: Data including preoperative and postoperative pad use and urinary leakage were available for 92 and 90 @entity1 , respectively. A decrease in the median 24 h urinary leakage (352.5 vs 11 ml, p < 0.001) and in the median number of pads used per day (4.75 vs 2.25, p = 0.001) was demonstrated. Forty-six @entity1 had a pad use of 0-1 pads per day and/or a daily urinary leakage less than 8 g, corresponding to an overall dry rate of 50%. A decrease in urinary leakage > 50% was seen in 72 @entity1 (80%). Complications were seen in 23 @entity1 . All of these were treated successfully by removal of the device in the outpatient setting followed by replacement of the device. Another eight @entity1 had a third balloon inserted to improve continence further. Fourteen @entity1 (12%) ended up with an artificial sphincter or a urethral sling. Sixty @entity1 (63%) experienced no discomfort and 58 (61%) reported being dry or markedly improved. Overall, 50 @entity1 (53%) reported being very or predominantly satisfied. CONCLUSIONS: Adjustable continence balloons seem to be a good alternative in the treatment of male @entity322 . Complications are mild and easily treated.

Adjustable continence balloons: clinical results of a new minimally invasive treatment for male XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'men'] @entity322 :: ('MESH:D014549', 'Disease') :: ['urinary incontinence']
@entity322 :: (MESH:D014549,Disease) :: ['urinary incontinence']
